Stock comparison
Medline Inc. is 1.5x more valuable than RESMED INC by market capitalization ($49.12 B vs $33.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 1.5x more valuable than RESMED INC by market capitalization ($49.12 B vs $33.09 B).
Market value leader
MDLN
Medline Inc. is 1.5x more valuable than RESMED INC by market capitalization ($49.12 B vs $33.09 B).
Revenue leader
MDLN
MDLN: $28.43B vs RMD: $5.65B.
Profit leader
MDLN
MDLN: $1.16T vs RMD: $1.52B.
Margin leader
MDLN
MDLN: 4069.4% vs RMD: 26.9% net margin.
| Metric | MDLN | RMD |
|---|---|---|
| Market cap | $49.12 B | $33.09 B |
| US-listed rank | #322 | #432 |
| Revenue (latest FY) | $28.43B | $5.65B |
| Net income (latest FY) | $1.16T | $1.52B |
| Net margin | 4069.4% | 26.9% |
| P/E (trailing FY) | 0.0x | 21.7x |
| SEC filings | 103 | 2,518 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 1.5x more valuable than RESMED INC by market capitalization ($49.12 B vs $33.09 B).
In their latest fiscal years, Medline Inc. reported $28.43B in revenue while RESMED INC reported $5.65B.
Full pages: Medline Inc. and RESMED INC, or browse the full rankings.